Filing Details

Accession Number:
0001209191-22-040108
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-01 15:11:10
Reporting Period:
2022-06-01
Accepted Time:
2022-07-01 15:11:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684087 Caroline Young 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-01 25 $2.05 16,496 No 4 P Direct
Common Stock Acquisiton 2022-06-02 25 $2.08 16,521 No 4 P Direct
Common Stock Acquisiton 2022-06-03 25 $2.09 16,546 No 4 P Direct
Common Stock Acquisiton 2022-06-06 27 $2.07 16,573 No 4 P Direct
Common Stock Acquisiton 2022-06-07 20 $2.08 16,593 No 4 P Direct
Common Stock Acquisiton 2022-06-08 27 $2.12 16,620 No 4 P Direct
Common Stock Acquisiton 2022-06-09 27 $2.09 16,647 No 4 P Direct
Common Stock Acquisiton 2022-06-10 27 $2.04 16,674 No 4 P Direct
Common Stock Acquisiton 2022-06-13 27 $2.01 16,701 No 4 P Direct
Common Stock Acquisiton 2022-06-14 27 $2.02 16,728 No 4 P Direct
Common Stock Acquisiton 2022-06-15 27 $1.98 15,755 No 4 P Direct
Common Stock Acquisiton 2022-06-16 27 $1.95 16,782 No 4 P Direct
Common Stock Acquisiton 2022-06-17 27 $1.94 16,809 No 4 P Direct
Common Stock Acquisiton 2022-06-21 28 $1.97 16,837 No 4 P Direct
Common Stock Acquisiton 2022-06-22 25 $1.99 16,862 No 4 P Direct
Common Stock Acquisiton 2022-06-23 28 $2.01 16,890 No 4 P Direct
Common Stock Acquisiton 2022-06-24 28 $2.11 16,918 No 4 P Direct
Common Stock Acquisiton 2022-06-27 7 $2.06 16,925 No 4 P Direct
Common Stock Acquisiton 2022-06-28 23 $2.06 16,948 No 4 P Direct
Common Stock Acquisiton 2022-06-29 28 $2.11 16,976 No 4 P Direct
Common Stock Acquisiton 2022-06-30 28 $2.08 17,004 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.